SFG
GILD icon

Strive Financial Group’s Gilead Sciences GILD Stock Holding History

Strive Financial Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$280K Buy
2,213
+1,740
+368% +$229K 0.12% 112
2026
Q1 		$66K Buy
473
+65
+16% +$9.1K 0.04% 196
2025
Q4 		$50.1K Buy
+408
New +$49.6K 0.03% 219

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Strive Financial Group's GILD Position: Q2 2026 in Review

Strive Financial Group increased its Gilead Sciences (GILD) stake by 368% in Q2 2026, buying an estimated $229K and bringing the position to 2,213 shares worth $280K. The position accounts for 0.12% of the portfolio, ranked #112.

Strive Financial Group first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Strive Financial Group held 2,213 shares of Gilead Sciences worth $280K as of Q2 2026.
  • Strive Financial Group bought 1,740 Gilead Sciences shares in Q2 2026, an estimated $229K.
  • Gilead Sciences made up 0.12% of Strive Financial Group's portfolio in Q2 2026, its #112 holding.
  • Strive Financial Group first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Strive Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.